STOCK TITAN

Sage Therapeutics to Report First Quarter 2022 Financial Results on Tuesday, May 3, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, May 3, 2022 at 8:00 a.m. ET to announce first quarter 2022 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available approximately two hours after the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit. www.sagerx.com.

Investor

Helen Rubinstein

315-382-3979

helen.rubinstein@sagerx.com

Media

Becky Kern

914-772-2310

becky.kern@sagerx.com

Source: Sage Therapeutics, Inc.

Sage Therapeutic

NASDAQ:SAGE

SAGE Rankings

SAGE Latest News

SAGE Latest SEC Filings

SAGE Stock Data

576.75M
56.11M
11.94%
79.96%
6.37%
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE